Perrigo is expected to face competition from Swiss food giant Nestle and the private equity owners of German drug firm Stada. Source: BioSpace

The approval was based on data from the Phase 3 Oral Psoriatic Arthritis Trial (OPAL) clinical development program. Source: BioSpace

Amgen tapped two companies to receive its coveted 2017 Golden Ticket at LabCentral. Source: BioSpace

Bruno Strigini, the CEO of Novartis Oncology, plans to exit the company's Executive Committee by Dec. 31, 2017, and leave entirely in early 2018. Source: BioSpace

Galapagos assumes 35% of the co-promotion efforts in Germany, France, Italy, Spain, the United Kingdom, the Netherlands, Belgium, and Luxembourg. Source: BioSpace

Nelson Cabatuan, Rigel's vice president, finance will serve as the company's interim principal accounting officer. Source: BioSpace

Clinical trial dosing will resume around year-end 2017. Source: BioSpace

Industry analysts were shocked when in July the FDA reversed course on Amicus' Phase III treatment for Fabry disease. Source: BioSpace

Now that 2017 is drawing to an end, though, it's time to focus on the new year. Source: BioSpace

argenx increased the Offering from the initially filed offering size of $150 million. Source: BioSpace